| Not Yet Recruiting | Mindfulness-based Intervention for Depressive Symptoms Sent Via Text (MINDSET) NCT06811454 | Case Comprehensive Cancer Center | N/A |
| Completed | Ask Questions (ASQ):Implementation of a Communication Intervention NCT05025748 | Barbara Ann Karmanos Cancer Institute | N/A |
| Active Not Recruiting | Researching the Effect of Exercise on Cancer NCT04589468 | Memorial Sloan Kettering Cancer Center | N/A |
| Completed | Effect of Treatment on Work Experience in Patients With Stage I-III Prostate Cancer NCT03963739 | Wake Forest University Health Sciences | — |
| Active Not Recruiting | Acupuncture Pilot Study for Cancer-related Cognitive Function NCT04007770 | Memorial Sloan Kettering Cancer Center | Phase 2 |
| Recruiting | Nutrition and Exercise Interventions in Reducing Androgen Deprivation Therapy-Induced Obese Frailty in Prostat NCT03880422 | Roswell Park Cancer Institute | N/A |
| Withdrawn | Stereotactic Body Radiation Therapy With REGN2810 and/or Ipilimumab Before Surgery in Treating Participants Wi NCT03477864 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Phase 1 |
| Completed | Acceptance and Commitment Therapy in Improving Well-Being in Patients With Stage III-IV Cancer and Their Partn NCT03112668 | Rutgers, The State University of New Jersey | N/A |
| Completed | Decision Aids in Improving Knowledge in Patients With Newly Diagnosed Prostate Cancer NCT03103321 | Alliance for Clinical Trials in Oncology | Phase 3 |
| Completed | Visually Enhanced Education About Prostate Cancer NCT02846870 | Vanderbilt-Ingram Cancer Center | N/A |
| Terminated | sEphB4-HSA Before Surgery in Treating Patients With Bladder Cancer, Prostate Cancer, or Kidney Cancer NCT02767921 | University of Southern California | Phase 1 |
| Completed | Nanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR Mutations NCT02646319 | Mayo Clinic | EARLY_Phase 1 |
| Completed | Enzalutamide Versus Standard Androgen Deprivation Therapy for the Treatment Hormone Sensitive Prostate Cancer NCT02278185 | University of Colorado, Denver | Phase 2 |
| Unknown | Cryoablation Therapy or Radiotherapy Therapy for Stage III Prostate Cancer NCT02605226 | Tianjin Medical University Cancer Institute and Hospital | N/A |
| Terminated | Metformin Hydrochloride and Aspirin in Treating Patients With Hormone-Dependent Prostate Cancer That Has Progr NCT02420652 | Rutgers, The State University of New Jersey | Phase 2 |
| Completed | Tangerine or Red Tomato Juice in Treating Patients With Prostate Cancer Undergoing Surgery NCT02144649 | Ohio State University Comprehensive Cancer Center | N/A |
| Completed | Intra-operative Optical Imaging With MDX1201-A488 in Patients With Prostate Cancer NCT02048150 | City of Hope Medical Center | Phase 1 |
| Active Not Recruiting | High-Dose Brachytherapy in Treating Patients With Prostate Cancer NCT02346253 | Stanford University | N/A |
| Completed | Phenelzine Sulfate in Treating Patients With Non-metastatic Recurrent Prostate Cancer NCT02217709 | University of Southern California | Phase 2 |
| Completed | A Pilot Study to Enhance F18 FDG-PET Imaging of Prostate Cancers With the Metabolic Inhibitor Ranolazine NCT01992016 | University of Colorado, Denver | N/A |
| Active Not Recruiting | Enzalutamide, Radiation Therapy and Hormone Therapy in Treating Patients With Intermediate or High-Risk Prosta NCT02023463 | Thomas Jefferson University | Phase 1 |
| Active Not Recruiting | Stereotactic Body Radiation Therapy in Treating Patients With Localized High-Risk Prostate Cancer NCT02296229 | Jonsson Comprehensive Cancer Center | N/A |
| Completed | Effect of Quercetin on Green Tea Polyphenol Uptake in Prostate Tissue From Patients With Prostate Cancer Under NCT01912820 | Jonsson Comprehensive Cancer Center | Phase 1 |
| Active Not Recruiting | Stereotactic Body Radiation Therapy in Treating Patients With Prostate Cancer After Undergoing Surgery NCT01923506 | City of Hope Medical Center | Phase 1 |
| Completed | Copper Cu 64 TP3805 PET in Detecting Cancer in Patients With Prostate Cancer Undergoing Surgery NCT02603965 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Phase 1 |
| Terminated | Cabozantinib in Men With Castration-Resistant Prostate Cancer NCT01703065 | University of Washington | Phase 2 |
| Completed | Degarelix Acetate Before and During Radiation Therapy in Treating Patients With Prostate Cancer NCT01731912 | University of Washington | N/A |
| Active Not Recruiting | Aborption and Metabolism of Lyophilized Black Raspberry Food Products in Men With Prostate Cancer Undergoing S NCT01823562 | Ohio State University Comprehensive Cancer Center | Phase 1 |
| Terminated | Cabazitaxel Plus Prednisone With Octreotide For Castration-Resistant Prostate Cancer (CRPC) Previously Treated NCT01469338 | University of Southern California | Phase 2 |
| Completed | High-Dose Stereotactic Radiation for Prostate Cancer NCT01664130 | Case Comprehensive Cancer Center | N/A |
| Withdrawn | Atorvastatin Calcium in Preventing Metabolic Syndrome in Prostate Cancer Patients Receiving Androgen-Deprivati NCT01555632 | University of Nebraska | N/A |
| Completed | Axitinib Before Surgery in Treating Patients With High-Risk Prostate Cancer NCT01385059 | City of Hope Medical Center | Phase 2 |
| Withdrawn | Omega-3 Fatty Acids in Treating Patients With Advanced Prostate Cancer NCT00996749 | Wake Forest University Health Sciences | N/A |
| Terminated | Genistein in Treating Patients With Prostate Cancer NCT01126879 | Northwestern University | Phase 2 |
| Completed | Docetaxel Plus Lycopene in Castration Resistant, Chemotherapy-Naïve Prostate Cancer Patients NCT01882985 | University of California, Irvine | Phase 2 |
| Completed | Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors NCT01155258 | University of Southern California | Phase 1 |
| Completed | Intensity-Modulated External Beam Radiation Therapy in Treating Patients With Prostate Cancer NCT01117935 | Virginia Commonwealth University | N/A |
| Completed | Abiraterone Prednisone and Hormonal Therapy Before and During Radiation Therapy in Localized Prostate Cancer NCT01023061 | University of Washington | Phase 2 |
| Completed | Whole Body Fluorine F 18 Sodium Fluoride PET/CT Scan and Whole Body MRI in Finding Bone Metastases in Patients NCT00956163 | National Cancer Institute (NCI) | EARLY_Phase 1 |
| Terminated | Leuprolide Acetate or Goserelin Acetate Compared With Observation in Treating Patients With High-Risk Prostate NCT00937768 | Mayo Clinic | Phase 2 |
| Terminated | Taxotere/Prednisone Plus Sunitinib in Chemotherapy-Naïve, Hormone Refractory Prostate Cancer Patients NCT00879619 | John P. Fruehauf | Phase 1 / Phase 2 |
| Completed | MRI-Guided Radiation Therapy in Treating Patients Who Have Undergone Surgery to Remove the Prostate NCT01028885 | Abramson Cancer Center at Penn Medicine | Phase 1 |
| Completed | Lycopene in Treating Patients Undergoing Radical Prostatectomy for Prostate Cancer NCT00450749 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Androgen Deprivation Therapy and Vorinostat Followed by Radical Prostatectomy in Treating Patients With Locali NCT00589472 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Bevacizumab in Treating Patients With Relapsed Prostate Cancer That Did Not Respond to Hormone Therapy NCT01656304 | Barbara Ann Karmanos Cancer Institute | Phase 2 |
| Completed | Sorafenib Tosylate and Gene Expression Analysis in Patients Undergoing Surgery For High-Risk Localized Prostat NCT00466752 | University of Washington | Phase 2 |
| Terminated | Calcitriol in Combination With Ketoconazole and Therapeutic Hydrocortisone in Treating Patients With Prostate NCT00536991 | Roswell Park Cancer Institute | Phase 1 / Phase 2 |
| Completed | A Phase II Study of PROSTVAC-V (Vaccinia)/TRICOM and PROSTVAC-F (Fowlpox)/TRICOM With GM-CSF in Patients With NCT00108732 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Lapatinib Ditosylate in Treating Patients With a Rising PSA Indicating Recurrent Prostate Cancer NCT00103194 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Cilengitide in Treating Patients With Prostate Cancer NCT00121238 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Hormone Therapy and Ipilimumab in Treating Patients With Advanced Prostate Cancer NCT00170157 | Mayo Clinic | Phase 2 |
| Completed | GTI-2040 and Docetaxel in Treating Patients With Recurrent, Metastatic, or Unresectable Locally Advanced Non-S NCT00074022 | National Cancer Institute (NCI) | Phase 1 / Phase 2 |
| Terminated | Perifosine in Treating Patients With Recurrent Prostate Cancer NCT00058214 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu NCT00004074 | National Cancer Institute (NCI) | Phase 1 |
| Withdrawn | Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Prostate Cancer NCT00003517 | Burzynski Research Institute | Phase 2 |